Advertisement
Screener

INMUNE BIO INC. (INMB) Tax Adjustments, Settlements, and Unusual Provisions

1.8 / 5 stars · 17/46 Roast Me

INMUNE BIO INC. Tax Adjustments, Settlements, and Unusual Provisions

INMUNE BIO INC. (INMB) reported Tax Adjustments, Settlements, and Unusual Provisions of $335.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.

Discontinued › Notes › Income Taxes

us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions · last filed 2024-03-28

  • INMUNE BIO INC. tax adjustments, settlements, and unusual provisions for fiscal 2023 was $335.00K.
  • INMUNE BIO INC. tax adjustments, settlements, and unusual provisions for fiscal 2022 was -$1.77M, a 1168.67% decline from fiscal 2021.
  • INMUNE BIO INC. tax adjustments, settlements, and unusual provisions for fiscal 2021 was $166.00K, a 403.03% increase from fiscal 2020.
  • INMUNE BIO INC. tax adjustments, settlements, and unusual provisions for fiscal 2020 was $33.00K.
Period endTax Adjustments, Settlements, and Unusual Provisions 12 month
2023-12-31$335.00K
10-K · filed 2024-03-28
2022-12-31-$1.77M
10-K · filed 2024-03-28
2021-12-31$166.00K
10-K · filed 2023-03-02
2020-12-31$33.00K
10-K · filed 2022-03-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
ImageneBio, Inc. (IMA)United States$0.056B-1.31
BioAtla, Inc. (BCAB)United States$0.058B-0.21
EXOZYMES INC. (EXOZ)United States$0.058B
Tevogen Inc. (TVGN)United States$0.049B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Instil Bio, Inc. (TIL)United States$0.048B-1.73
LeonaBio, Inc. (LONA)United States$0.047B-0.61
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
BioStem Technologies, Inc. (BSEM)United States$0.069B